These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 9425904)
1. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Bullido MJ; Artiga MJ; Recuero M; Sastre I; García MA; Aldudo J; Lendon C; Han SW; Morris JC; Frank A; Vázquez J; Goate A; Valdivieso F Nat Genet; 1998 Jan; 18(1):69-71. PubMed ID: 9425904 [TBL] [Abstract][Full Text] [Related]
3. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population. Zurutuza L; Verpillat P; Raux G; Hannequin D; Puel M; Belliard S; Michon A; Pothin Y; Camuzat A; Penet C; Martin C; Brice A; Campion D; Clerget-Darpoux F; Frebourg T Eur J Hum Genet; 2000 Sep; 8(9):713-6. PubMed ID: 10980578 [TBL] [Abstract][Full Text] [Related]
4. Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study. Roks G; Cruts M; Houwing-Duistermaat JJ; Dermaut B; Serneels S; Havekes LM; Hofman A; Breteler MM; Van Broeckhoven C; van Duijn CM Am J Med Genet; 2002 Jul; 114(5):570-3. PubMed ID: 12116196 [TBL] [Abstract][Full Text] [Related]
5. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E gene promoter polymorphisms in Alzheimer's disease. Bullido MJ; Valdivieso F Microsc Res Tech; 2000 Aug; 50(4):261-7. PubMed ID: 10936877 [TBL] [Abstract][Full Text] [Related]
7. Distribution of apolipoprotein E4 isoform in Alzheimer's disease in Poland. Bratosiewicz-Zapart J; Kłoszewska I; Sobów T; Liberski PP Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):221-2. PubMed ID: 9597090 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease. Tilley L; Morgan K; Grainger J; Marsters P; Morgan L; Lowe J; Xuereb J; Wischik C; Harrington C; Kalsheker N Eur J Hum Genet; 1999 Sep; 7(6):659-63. PubMed ID: 10482954 [TBL] [Abstract][Full Text] [Related]
9. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele. Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457 [TBL] [Abstract][Full Text] [Related]
10. [Apolipoprotein E genotypes in patients investigated for dementia]. Johannsen P; Jakobsen JK; Jørgensen AL Ugeskr Laeger; 1997 Sep; 159(38):5658-61. PubMed ID: 9340872 [TBL] [Abstract][Full Text] [Related]
11. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk. Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401 [TBL] [Abstract][Full Text] [Related]
12. No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples. Fallin D; Gauntlett AC; Scibelli P; Cai X; Duara R; Gold M; Crawford F; Mullan M Genet Epidemiol; 1997; 14(3):299-305. PubMed ID: 9181358 [TBL] [Abstract][Full Text] [Related]
13. Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study. Quan W; Yasuda M; Hashimoto M; Yamamoto Y; Ishii K; Kazui H; Mori E; Kakigi T; Maeda K J Neurol Sci; 2006 Jan; 240(1-2):71-5. PubMed ID: 16233903 [TBL] [Abstract][Full Text] [Related]
14. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele. Riemenschneider M; Schwarz S; Wagenpfeil S; Diehl J; Müller U; Förstl H; Kurz A Mol Psychiatry; 2002; 7(7):782-5. PubMed ID: 12192623 [TBL] [Abstract][Full Text] [Related]
15. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele. Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606 [TBL] [Abstract][Full Text] [Related]
16. The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia. Geschwind D; Karrim J; Nelson SF; Miller B Ann Neurol; 1998 Jul; 44(1):134-8. PubMed ID: 9667603 [TBL] [Abstract][Full Text] [Related]
17. [The relation between alpha1-antichymotrypsin gene polymorphism and epsilon4 allele of apolipoprotein E gene in Alzheimer disease in Chinese]. Tang G; Jiang S; Gu N; Jin T; Lin S; Qian Y; Wang D; Zhang M Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Apr; 16(2):94-6. PubMed ID: 10194255 [TBL] [Abstract][Full Text] [Related]
18. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily. Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878 [TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of APOE and LRP genes in Brazilian individuals with Alzheimer disease. Bahia VS; Kok F; Marie SN; Shinjo SO; Caramelli P; Nitrini R Alzheimer Dis Assoc Disord; 2008; 22(1):61-5. PubMed ID: 18317248 [TBL] [Abstract][Full Text] [Related]